Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements

被引:108
作者
Ng, QS
Goh, V
Fichte, H
Klotz, E
Fernie, P
Saunders, MI
Hoskin, PJ
Padhani, AR
机构
[1] Mt Vernon Hosp, Paul Strickland Scanner Ctr, Northwood HA6 2RN, Middx, England
[2] Siemens Med Solut, Forchheim, Germany
关键词
D O I
10.1148/radiol.2392050568
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Institutional review board approval and informed consent were obtained for this study. The aim of the study was to prospectively assess, in patients with lung cancer, the reproducibility of a quantitative whole tumor perfusion computed tomographic (CT) technique. Paired CT studies were performed in 10 patients (eight men, two women; mean age, 66 years) with lung cancer. Whole tumor permeability and blood volume were measured, and reproducibility was evaluated by using Bland-Altman statistics. Coefficient of variation of 9.49% for permeability and 26.31% for blood volume and inter- and intraobserver variability ranging between 3.30% and 6.34% indicate reliable assessment with this whole tumor technique. (c) RSNA, 2006.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 27 条
  • [1] Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate
    Anderson, HL
    Yap, JT
    Miller, MP
    Robbins, A
    Jones, T
    Price, PM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2823 - 2830
  • [2] Applying the right statistics: analyses of measurement studies
    Bland, JM
    Altman, DG
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 22 (01) : 85 - 93
  • [3] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [4] Cenic A, 2000, AM J NEURORADIOL, V21, P462
  • [5] TEMPORAL HETEROGENEITY IN MICROREGIONAL ERYTHROCYTE FLUX IN EXPERIMENTAL SOLID TUMORS
    CHAPLIN, DJ
    HILL, SA
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (06) : 1210 - 1213
  • [6] Angiogenesis inhibitors in clinical development; where are we now and where are we going?
    Eskens, FALM
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 1 - 7
  • [7] Fiorella D, 2004, AM J NEURORADIOL, V25, P97
  • [8] Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis
    Galbraith, SM
    Lodge, MA
    Taylor, NJ
    Rustin, GJS
    Bentzen, S
    Stirling, JJ
    Padhani, AR
    [J]. NMR IN BIOMEDICINE, 2002, 15 (02) : 132 - 142
  • [9] Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging
    Galbraith, SM
    Maxwell, RJ
    Lodge, MA
    Tozer, GM
    Wilson, J
    Taylor, NJ
    Stirling, JJ
    Sena, L
    Padhani, AR
    Rustin, GJS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2831 - 2842
  • [10] Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement
    Goh, V
    Halligan, S
    Hugill, JA
    Bassett, P
    Bartram, CI
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (01) : 225 - 231